Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hyperlipoproteinemias

  Free Subscription


Articles published in Can J Cardiol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    October 2018
  1. IACOCCA MA, Wang J, Sarkar S, Dron JS, et al
    Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia.
    Can J Cardiol. 2018;34:1316-1324.
    PubMed     Text format     Abstract available


  2. PAQUETTE M, Baass A
    A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication.
    Can J Cardiol. 2018;34:1259-1260.
    PubMed     Text format    


    August 2018
  3. BAASS A, Hegele RA
    Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia.
    Can J Cardiol. 2018;34:959-961.
    PubMed     Text format    


  4. RAZEK O, Cermakova L, Armani H, Lee T, et al
    Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors.
    Can J Cardiol. 2018;34:1004-1009.
    PubMed     Text format     Abstract available


    July 2018
  5. MCPHERSON R
    The Cardiovascular Burden of Undiagnosed Familial Hypercholesterolemia: Need to Modify Guidelines to Encourage Earlier Diagnosis and Therapy.
    Can J Cardiol. 2018 Jul 11. pii: S0828-282X(18)30503.
    PubMed     Text format    


    May 2018
  6. RUEL I, Brisson D, Aljenedil S, Awan Z, et al
    Simplified Canadian Definition for Familial Hypercholesterolemia.
    Can J Cardiol. 2018 May 19. pii: S0828-282X(18)30383.
    PubMed     Text format     Abstract available


    October 2017
  7. PAQUETTE M, Dufour R, Baass A
    Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
    Can J Cardiol. 2017;33:1312-1318.
    PubMed     Text format     Abstract available


    May 2017
  8. AL KINDI M, Belanger AM, Sayegh K, Senouci S, et al
    Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.
    Can J Cardiol. 2017;33:658-665.
    PubMed     Text format     Abstract available


  9. RAJAMANNAN NM, Nattel S
    Aortic Vascular Calcification: Cholesterol Lowering Does Not Reduce Progression in Patients With Familial Hypercholesterolemia-or Does It?
    Can J Cardiol. 2017;33:594-596.
    PubMed     Text format    


  10. NAUGLER C, Cook C, Morrin L, Wesenberg J, et al
    Statin Prescriptions for High-Risk Patients Are Increased by Laboratory-Initiated Framingham Risk Scores: A Quality-Improvement Initiative.
    Can J Cardiol. 2017;33:682-684.
    PubMed     Text format     Abstract available


  11. BRENNAN ET, Joy TR
    Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
    Can J Cardiol. 2017;33:666-673.
    PubMed     Text format     Abstract available


    March 2017
  12. FILLER G, Lee M, Hegele RA
    Barriers to the Implementation of Lipoprotein Apheresis in Canada.
    Can J Cardiol. 2017;33:409-411.
    PubMed     Text format     Abstract available


  13. WATERS DD, Boekholdt SM
    An Evidence-Based Guide to Cholesterol-Lowering Guidelines.
    Can J Cardiol. 2017;33:343-349.
    PubMed     Text format     Abstract available


    November 2016
  14. GENEST J
    Familial Hypercholesterolemia: Awareness, Appraisal, and Action.
    Can J Cardiol. 2016 Nov 14. pii: S0828-282X(16)31014.
    PubMed     Text format    


    September 2016
  15. BRUNHAM LR, Cermakova L, Lee T, Priecelova I, et al
    Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study.
    Can J Cardiol. 2016 Sep 3. pii: S0828-282X(16)30892.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: